7 HA'ESHEL ST., POB 3163, CAESAREA, L3
Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
Announces Resignation of Mr. Vincent Chun Hung Chan from the Board of Directors
Class Action Certification Approved by Tel Aviv District Court
Regains Compliance with Nasdaq Minimum Bid Price Requirement
Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Prospectus filed pursuant to Rule 424(b)(5)
No filings found
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement
Correspondence
Free Writing Prospectus